The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bard Medical; Ferring; Ipsen; Janssen; Sanofi
Consulting or Advisory Role - Bard Medical; Ferring; Ipsen; Janssen; Sanofi
Main reasons of choice of formulation and route of triptorelin treatment initiated in patients with prostate cancer (PCa): TALISMAN study.
 
Antoine Thiery-Vuillemin
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi
Research Funding - Bayer (Inst); Ipsen (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Pfizer; Roche
 
Gilles Crehange
No Relationships to Disclose
 
Thierry Lebret
Honoraria - AstraZeneca; Bayer; Ipsen; Roche
Consulting or Advisory Role - Ipsen
 
Nathalie Pello Leprince Ringuet
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Valérie Perrot
Employment - Ipsen
Stock and Other Ownership Interests - Ipsen
 
Jerome Rigaud
Honoraria - Astellas Pharma; Intuitive Surgical; Ipsen; Janssen; Recordati; Takeda
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Ipsen; Janssen